Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Our clinical team is comprised of highly-skilled weight-loss experts and we are prepared to help you achieve your weight-loss goals with Contact us today
Individuals with active hepatitis or acute liver injury from any cause should generally defer initiation of new medications, including semaglutide, until the acute process has resolved and liver function has stabilized
In Canada, all of these weight loss medications can be used in adult patients with an initial body mass index (BMI) of: 30 Kg/m2 or greater, or 27 Kg/m2 or greater in the presence of at least one weight-related comorbidity (ie, high blood pressure, type 2 diabetes, high cholesterol, fatty liver, sleep apnea, etc) To find out if any of these agents are covered on your benefits plan, use each of the drug identification numbers (DIN) listed below each medication name to check with your benefits plan or pharmacy
Important safety considerations from the FDA label include: Zepbound is not recommended for patients with severe gastrointestinal disease, including severe gastroparesis Zepbound may reduce the effectiveness of oral contraceptives
US$ 29.13
US$ 27.73
US$ 21.81
